Hyderabad: The Drugs Controller General of India (DGCI) has given permission to Bharat Biotech to test its COVID-19 vaccine, COVAXIN, by administering it via the skin.
This intradermal vaccine delivery route is less invasive and will require a lesser dosage as well. The inactive virus-based vaccine is also being tested to be delivered in the intramuscular way.
Currently, the indigenously built vaccine is in phase II trials.
New York: Elon Musk has emerged as a key man in President-elect Donald Trump’s administration, which…
Bhubaneswar: In order to strengthen meteorological forecasting capabilities, steps are being taken to install three…
Bhubaneswar: Burglars decamped with gold ornaments worth around Rs 30 lakh from a house at…
New Delhi: The Delhi High Court on Monday dismissed the anticipatory bail plea of former IAS…
Bhubaneswar: After untimely rains for two consecutive days last week, Odisha is likely to experience…
Hyderabad: PV Sindhu and Venkata Datta Sai are man and wife now. India’s ace shuttler and…
This website uses cookies.